LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Petithomme-Nanrocki, Maiwenn"
  2. AU=Zhou Ping

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Impact of Open Access status on journal metrics in infectious diseases and clinical microbiology - A cross-sectional study.

    Tau, Noam / Moutel, Marin / Petithomme-Nanrocki, Maiwenn / Hentzien, Maxime / Yahav, Dafna

    Infectious diseases now

    2024  Volume 54, Issue 4, Page(s) 104909

    Abstract: Introduction: While Open Access (OA) journals provide free access to articles, they entail high article processing charges (APC), limiting opportunities for young researchers and those from low-middle income countries to publish OA.: Methods: Cross- ... ...

    Abstract Introduction: While Open Access (OA) journals provide free access to articles, they entail high article processing charges (APC), limiting opportunities for young researchers and those from low-middle income countries to publish OA.
    Methods: Cross-sectional study, evaluating APC and academic impact of full OA (FOA) journals in infectious diseases (ID) and clinical microbiology (CM) compared to hybrid journals. Data were collected from Journal Citation Reports and journals' websites.
    Results: Among 255 journals, median APC was 2850 (interquartile range [IQR] 1325-3654$). Median APC for 120 FOA journals was significantly lower than for 119 hybrid journals (2000, IQR 648-2767$ versus 3550, IQR 2948-4120$, p < 0.001). FOA journals had lower citation numbers and impact metrics compared to hybrid journals.
    Conclusion: While FOA ID/CM journals have lower APCs, they also lower academic impact compared to hybrid journals. These findings highlight the need for reforms in the publication process in view of achieving equitable data dissemination.
    Language English
    Publishing date 2024-04-13
    Publishing country France
    Document type Journal Article
    ISSN 2666-9919
    ISSN (online) 2666-9919
    DOI 10.1016/j.idnow.2024.104909
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Early switching from intravenous to oral antibiotic therapy in bone and joint infections associated with methicillin-susceptible Staphylococcus aureus bacteremia.

    Petithomme-Nanrocki, Maïwenn / Vernet-Garnier, Véronique / Lebrun, Delphine / Bajolet, Odile / Bonnet, Morgane / Hentzien, Maxime / Ohl, Xavier / Diallo, Saidou / Bani-Sadr, Firouzé

    Infectious diseases now

    2023  Volume 53, Issue 6, Page(s) 104739

    Abstract: Objectives: We aimed to evaluate the clinical outcomes of patients with bone and joint infection (BJI) associated with methicillin-susceptible Staphylococcus aureus bacteremia (MSSAB) treated with early oral switch to oral antibiotics (before day 14) ... ...

    Abstract Objectives: We aimed to evaluate the clinical outcomes of patients with bone and joint infection (BJI) associated with methicillin-susceptible Staphylococcus aureus bacteremia (MSSAB) treated with early oral switch to oral antibiotics (before day 14) versus later or no switch.
    Patients and methods: We included all cases reported between January 2016 and December 2021 in the University Hospital of Reims.
    Results: Among 79 patients with BJI associated with MSSAB, 50.6% had an early switch to oral antibiotics, with median duration of intravenous antibiotics of 9 (IQR 6-11) days. The overall cure rate was 81% with follow-up of 6 months, and was 85.7% after excluding the 9 patients whose death was not related to BJI infection. Failure to control BJI did not differ between the two groups.
    Conclusion: An early (before day 14) switch to oral antibiotics may be a safe therapeutic option in BJI associated with MSSAB.
    MeSH term(s) Humans ; Staphylococcus aureus ; Methicillin/therapeutic use ; Methicillin-Resistant Staphylococcus aureus ; Staphylococcal Infections/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Arthritis, Infectious/drug therapy ; Bacteremia/drug therapy
    Chemical Substances Methicillin (Q91FH1328A) ; Anti-Bacterial Agents
    Language English
    Publishing date 2023-06-16
    Publishing country France
    Document type Journal Article
    ISSN 2666-9919
    ISSN (online) 2666-9919
    DOI 10.1016/j.idnow.2023.104739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top